These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 15020278

  • 1. Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment.
    Makis AC, Hatzimichael EC, Kolios G, Bourantas KL.
    Haematologica; 2004 Mar; 89(3):360-1. PubMed ID: 15020278
    [Abstract] [Full Text] [Related]

  • 2. Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
    Lapouméroulie C, Benkerrou M, Odièvre MH, Ducrocq R, Brun M, Elion J.
    Haematologica; 2005 Mar; 90(3):401-3. PubMed ID: 15749673
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA.
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [Abstract] [Full Text] [Related]

  • 5. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N, Fattori A, Saad ST, Costa FF.
    Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT, Van Dreden P, Chaari M, Galea V, Khaterchi A, Lionnet F, Stankovic-Stojanovic K, Blanc-Brude O, Woodhams B, Maier-Redelsperger M, Girot R, Hatmi M, Elalamy I.
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy.
    Iyamu EW, Cecil R, Parkin L, Woods G, Ohene-Frempong K, Asakura T.
    Br J Haematol; 2005 Nov; 131(3):389-94. PubMed ID: 16225659
    [Abstract] [Full Text] [Related]

  • 11. Hydroxyurea and new agents for the treatment of sickle cell disease.
    Rodgers GP.
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia].
    Elira Dokekias A, Okandze Elenga JP, Ndinga J, Sanogo I, Sangare A.
    Tunis Med; 2005 Jan; 83(1):32-7. PubMed ID: 15881719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hydroxyurea therapy lowers circulating DNA levels in sickle cell anemia.
    Ulug P, Vasavda N, Kumar R, Keir L, Awogbade M, Cunningham J, Rees DC, Menzel S, Thein SL.
    Am J Hematol; 2008 Sep; 83(9):714-6. PubMed ID: 18615556
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
    Ritho J, Liu H, Hartzema AG, Lottenberg R.
    Am J Hematol; 2011 Oct; 86(10):888-90. PubMed ID: 21922530
    [No Abstract] [Full Text] [Related]

  • 16. Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell disease.
    Bachir D, Hulin A, Huet E, Habibi A, Nzouakou R, El Mahrab M, Astier A, Galacteros F.
    Hemoglobin; 2007 Oct; 31(4):417-25. PubMed ID: 17994375
    [Abstract] [Full Text] [Related]

  • 17. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyurea in children: present and future.
    Vichinsky EP.
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):22-9. PubMed ID: 9317198
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
    Lemonne N, Charlot K, Waltz X, Ballas SK, Lamarre Y, Lee K, Hierso R, Connes C, Etienne-Julan M, Romana M, Connes P.
    Haematologica; 2015 Oct; 100(10):e383-6. PubMed ID: 26137960
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.